By contrast, CX3CR1 levels appeared significantly increased in both study groups (FM and non-FM individuals), indicating that MT triggers this change in all individuals, with the exception of those FM patients co-diagnosed with ME/CFS. This evidence concerns the gene CX3CR1 and myalgic encephalomeyelitis/chronic fatigue syndrome.